Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) EBIT (2020 - 2025)

Historic EBIT for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $2.8 million.

  • IM Cannabis' EBIT rose 45399.35% to $2.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.3 billion, marking a year-over-year increase of 7285478.39%. This contributed to the annual value of $7.5 billion for FY2024, which is 9870512.17% up from last year.
  • Per IM Cannabis' latest filing, its EBIT stood at $2.8 million for Q3 2025, which was up 45399.35% from -$140012.2 recorded in Q2 2025.
  • IM Cannabis' EBIT's 5-year high stood at $9.3 billion during Q4 2021, with a 5-year trough of -$98.3 million in Q3 2022.
  • In the last 5 years, IM Cannabis' EBIT had a median value of -$1.6 million in 2023 and averaged $881.9 million.
  • Its EBIT has fluctuated over the past 5 years, first plummeted by 208726.42% in 2022, then soared by 28373468.33% in 2024.
  • IM Cannabis' EBIT (Quarter) stood at $9.3 billion in 2021, then tumbled by 97.23% to $257.2 million in 2022, then crashed by 101.01% to -$2.6 million in 2023, then surged by 283734.68% to $7.3 billion in 2024, then tumbled by 99.96% to $2.8 million in 2025.
  • Its EBIT was $2.8 million in Q3 2025, compared to -$140012.2 in Q2 2025 and $110112.8 in Q1 2025.